Nuvo Pharmaceuticals Inc.

Informe acción TSX:MRV

Capitalización de mercado: CA$15.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Dividendos de Nuvo Pharmaceuticals

Dividendo controles de criterios 0/6

Información clave

n/a

Rentabilidad por dividendo

n/a

Ratio de pago

Rentabilidad media de la industria2.3%
Próxima fecha de pago de dividendosn/a
Fecha ex dividendon/a
Dividendo por acciónn/a
Beneficios por acciónCA$1.33
Rentabilidad por dividendo prevista a 3 añosn/a

Últimas actualizaciones de dividendos

No hay actualizaciones

Recent updates

Nuvo Pharmaceuticals (TSE:MRV) Has A Somewhat Strained Balance Sheet

Aug 17
Nuvo Pharmaceuticals (TSE:MRV) Has A Somewhat Strained Balance Sheet

Is Nuvo Pharmaceuticals (TSE:MRV) Using Too Much Debt?

Sep 01
Is Nuvo Pharmaceuticals (TSE:MRV) Using Too Much Debt?

Nuvo Pharmaceuticals Inc.'s (TSE:MRV) CEO Might Not Expect Shareholders To Be So Generous This Year

May 11
Nuvo Pharmaceuticals Inc.'s (TSE:MRV) CEO Might Not Expect Shareholders To Be So Generous This Year

These 4 Measures Indicate That Nuvo Pharmaceuticals (TSE:MRV) Is Using Debt Extensively

Feb 22
These 4 Measures Indicate That Nuvo Pharmaceuticals (TSE:MRV) Is Using Debt Extensively

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: Insufficient data to determine if MRV's dividends per share have been stable in the past.

Dividendo creciente: Insufficient data to determine if MRV's dividend payments have been increasing.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Nuvo Pharmaceuticals vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de MRV con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (MRV)n/a
Suelo de mercado 25% (CA)1.9%
Techo de mercado 25% (CA)6.3%
Media de la industria (Pharmaceuticals)2.3%
Previsión de analistas en 3 años (MRV)n/a

Dividendo destacado: Unable to evaluate MRV's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Alto dividendo: Unable to evaluate MRV's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Pago de beneficios a los accionistas

Cobertura de los beneficios: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: Unable to calculate sustainability of dividends as MRV has not reported any payouts.


Discover strong dividend paying companies